We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

179 hedge funds and large institutions have $1.81B invested in Acorda Therapeutics in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 68 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $5.04M

30% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 20

19% more capital invested

Capital invested by funds: $1.52B → $1.81B (+$293M)

3% more funds holding

Funds holding: 174 → 179 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 68

Holders
179
Holders Change
+5
Holders Change %
+2.87%
% of All Funds
4.77%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
55
Reduced
68
Closed
20
Calls
$12.9M
Puts
$5.04M
Net Calls
+$7.88M
Net Calls Change
+$2.93M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$18.8M
2
VAM
Visium Asset Management
New York
+$18.7M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$8.86M
4
Charles Schwab
Charles Schwab
California
+$7.87M
5
BFA
BlackRock Fund Advisors
California
+$7.82M

Top Sellers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
-$29.3M
2
PHS
PFM Health Sciences
California
-$12.6M
3
MACM
March Altus Capital Management
Connecticut
-$10.3M
4
PCM
Penn Capital Management
Pennsylvania
-$9.32M
5
RFC
Russell Frank Company
Washington
-$6.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
101
Metropolitan Life Insurance Company (MetLife)
New York
$1.33M – – –
Arrowstreet Capital
102
Arrowstreet Capital
Massachusetts
$1.32M +$1.15M +269 New
JP Morgan Chase
103
JP Morgan Chase
New York
$1.3M -$116K -27 -9%
DCM
104
Dupont Capital Management
Delaware
$1.3M -$412K -96 -27%
Royal Bank of Canada
105
Royal Bank of Canada
Ontario, Canada
$1.3M +$1.08M +251 +1,793%
AIG
106
American International Group
New York
$1.28M -$30K -7 -3%
PIM
107
Partner Investment Management
California
$1.27M +$112K +26 +11%
AL
108
Airain Ltd
Guernsey
$1.21M +$494K +115 +87%
SGAM
109
Smith Group Asset Management
Texas
$1.2M +$1.05M +244 New
ASRS
110
Arizona State Retirement System
Arizona
$1.2M +$12.9K +3 +1%
PPA
111
Parametric Portfolio Associates
Washington
$1.14M +$81.5K +19 +9%
CAM
112
ClariVest Asset Management
California
$1.06M +$931K +217 New
PAM
113
Paradigm Asset Management
New York
$1.02M -$51.5K -12 -5%
VRS
114
Virginia Retirement Systems
Virginia
$1.01M -$429K -100 -33%
D.E. Shaw & Co
115
D.E. Shaw & Co
New York
$959K -$1.53M -357 -65%
DekaBank Deutsche Girozentrale
116
DekaBank Deutsche Girozentrale
Germany
$910K -$68.7K -16 -8%
Connor, Clark & Lunn Investment Management (CC&L)
117
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$903K +$790K +184 New
LSERS
118
Louisiana State Employees Retirement System
Louisiana
$801K +$12.9K +3 +2%
CAM
119
Capstone Asset Management
Texas
$776K -$300K -70 -31%
USAA
120
United Services Automobile Association
Texas
$717K +$219K +51 +54%
SG Americas Securities
121
SG Americas Securities
New York
$716K +$403K +94 +181%
Susquehanna International Group
122
Susquehanna International Group
Pennsylvania
$675K -$120K -28 -17%
Two Sigma Investments
123
Two Sigma Investments
New York
$673K -$2.04M -476 -78%
CWG
124
C WorldWide Group
Denmark
$654K +$571K +133 New
TAM
125
Tocqueville Asset Management
New York
$613K – – –
3 4
5
6 7

ACOR Hedge Fund Activity: Q4 2014 in Review

179 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2014, worth a combined $1.81B — up 19% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ACOR positions and 20 closed out — a net gain of 6 holders — while 55 added to existing stakes and 68 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $18.8M. The largest seller was Oracle Investment Management, cutting an estimated $29.3M.

  • 179 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2014, up from 174 in Q3 2014.
  • Funds reported $1.81B of Acorda Therapeutics stock for Q4 2014, up 19% quarter-over-quarter.
  • 26 funds opened new Acorda Therapeutics positions in Q4 2014 and 20 closed out, a net change of +6 holders.
  • The largest Acorda Therapeutics buyer in Q4 2014 was Wellington Management Group, an estimated $18.8M added.
  • The largest Acorda Therapeutics seller in Q4 2014 was Oracle Investment Management, an estimated $29.3M sold.

Based on aggregated 13F filings for Q4 2014.